This approach is particularly relevant in our study because TNFα and IL-1β were found to be expressed persistently in breast tumors, to exert powerful and causative tumor-promoting roles, and to be significantly associated with poor prognosis in patients [16,17,18,19,20,21,22,23,24,25,26,27]. This evidence concerns the gene IL1B and neoplasm.